Bio-Rad Laboratories Inc. - Ordinary Shares - Class A
BIO
Market Cap$8.2B
Close$
$145.96
48.8% downside
Current Fair Value
48.8% downsideOvervalued by 48.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $8.20 Billion |
|---|---|
| Enterprise Value | $7.79 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-21.82 |
| Beta | 0.8 |
| Outstanding Shares | 24,100,000 |
| Avg 30 Day Volume | 202,322 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -12.86 |
|---|---|
| PEG | 22.16 |
| Price to Sales | 2.59 |
| Price to Book Ratio | 0.79 |
| Enterprise Value to Revenue | 2.92 |
| Enterprise Value to EBIT | 23.07 |
| Enterprise Value to Net Income | -13 |
| Total Debt to Enterprise | 0.15 |
| Debt to Equity | 0.14 |
Revenue Sources
No data
ESG Score
No data
About Bio-Rad Laboratories Inc.
CEO: Norman Schwartz